Application 210612
- Type
- ANDA
- Sponsor
- NOVAST LABS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ESTRADIOL AND NORETHINDRONE ACETATE | ESTRADIOL; NORETHINDRONE ACETATE | TABLET;ORAL | 0.5MG;0.1MG | No | No |
| 002 | ESTRADIOL AND NORETHINDRONE ACETATE | ESTRADIOL; NORETHINDRONE ACETATE | TABLET;ORAL | 1MG;0.5MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50742-657 | Estradiol and Norethindrone Acetate | Estradiol and Norethindrone Acetate | Ingenus Pharmaceuticals, LLC | ANDA | Current |
| 50742-657 | Estradiol and Norethindrone Acetate | Estradiol and Norethindrone Acetate | Ingenus Pharmaceuticals, LLC | ANDA | Current |
| 50742-658 | Estradiol and Norethindrone Acetate | Estradiol and Norethindrone Acetate | Ingenus Pharmaceuticals, LLC | ANDA | Current |
| 50742-658 | Estradiol and Norethindrone Acetate | Estradiol and Norethindrone Acetate | Ingenus Pharmaceuticals, LLC | ANDA | Current |